| Status | Study |
| Not yet recruiting |
Study Name: Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma Condition: Anemia B-Cell Prolymphocytic Leukemia Fatigue Date: 2017-01-03 Interventions: Drug: Entospletinib Given PO |
| Recruiting |
Study Name: Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Condition: Anemia Fatigue Fever Lym Date: 2016-10-26 Interventions: Other: Laboratory Biomarker Analysis |
| Recruiting |
Study Name: Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis Condition: Monoclonal B-Cell Lymphocytosis Stage 0 Chronic Lymphocytic Leu Date: 2014-12-03 Interventions: Other: Laboratory Biomarker Analysis |
| Enrolling by invitation |
Study Name: B-Cell Hematologic Malignancy Vaccination Registry Condition: Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma Date: 2014-11-20 |
| Recruiting |
Study Name: Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome Condition: Monoclonal Gammopathy of Undetermined Significance (MGUS) Chronic Lymphocytic Leukemia (CLL) Date: 2014-10-09 |
| Recruiting |
Study Name: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant Condition: Chronic Myeloid Leukemia (CML) Acute Myelogenous Leukemia (AML); Date: 2014-02-11 Interventions: Device: CliniMACS CD34+ Reagent System |
| Active, not recruiting |
Study Name: Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Condition: Anemia Chronic Lymphocytic Leukemia Fatigue Date: 2014-01-27 Interventions: Drug: Cyclophosphamide Given I |
| Recruiting |
Study Name: CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease Condition: Bone Marrow Failure Syndrome Severe Aplastic Anemia Severe Date: 2013-10-17 Interventions: Biological: CD34 Stem Cell Selection Therapy The CliniMacs (PLUS) Reagent System (Miltenyi CliniMacs CD3 |
| Withdrawn |
Study Name: Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis Condition: Apoptotic DNA Damage Rheumatoid Arthritis T-cell Date: 2012-10-24 Interventions: Drug: Group 1 or Orencia treated group |
| Recruiting |
Study Name: Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study Condition: Multiple Myeloma Leukemia MGUS Date: 2010-06-05 |